Longwood Fund

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events
  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-101 for the Treatment of Hematologic Malignancies

May 31, 2022

Colorescience Reveals Clinical Study Results of the Finishing Touchâ„¢ Skincare Protocol Following Facial Radiofrequency Microneedling Procedures

May 27, 2022

Werewolf Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights

May 11, 2022

TScan Therapeutics Reports First Quarter 2022 Financial Results and Upcoming Anticipated Milestones

May 10, 2022

Lassen Therapeutics Announces Presentations on Novel IL-11 Receptor-Blocking Antibody

May 4, 2022

Be Bio uses $130M Financing Round to Harness ‘Power of the B Cell’

April 15, 2022
« Older Entries
Newer Entries »

Longwood Fund

The Prudential Tower

800 Boylston Street
Suite 1715
Boston, MA, 02199

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

© Longwood Fund. All Rights Reserved